Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis.

Name: Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis.
Author: Liu, Dan

Dipeptidyl peptidase 4 (DPP-4) inhibitors and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM): a systematic review and meta-analysis. — المؤلف: Liu, Dan — BMC pharmacology & toxicology 20190909

المؤلف: Liu, Dan
النشر: BMC pharmacology & toxicology 20190909
الوصف: 15 p.
الموضوعات: Cardiovascular Diseases؛ Diabetes Mellitus, Type 2؛ Dipeptidyl-Peptidase IV Inhibitors؛ Observational Studies as Topic؛ Odds Ratio؛ Randomized Controlled Trials as Topic